GlassScriptPhysician profile
Manu Aggarwal
NPI 1477740157
$19,929.34
in general payments reported to CMS, 2019-2025
15 companies · $5,598 in 2025
The $5,598 reported for 2025 was more than what 99% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $115 · 2021: $128 · 2022: $469 · 2023: $3,205 · 2024: $10K · 2025: $5,598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $2,313 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,000 · Travel and Lodging: $1,954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $12,550.00 |
| Food and Beverage | $2,313.31 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,000.00 |
| Travel and Lodging | $1,954.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $17,764.02 | 2019-2025 | Entre Plus, Flexitouch Plus, Flexitouch Plus |
| Philips North America LLC | $624.35 | 2022-2025 | Azurion 7 M20, Image Guided Therapy Agito, (5153) Azurion 5 M20 Gc |
| Novo Nordisk INC | $395.42 | 2023-2025 | Wegovy |
| Surgenex LLC | $318.31 | 2025 | Renograft, Surgraft, Ardeograft |
| Boston Scientific Corporation | $207.89 | 2020-2025 | Varithena Administration Pack |
| Cashflow Solutions, LLC | $203.13 | 2023-2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Biocompatibles, INC. | $130.84 | 2019 | |
| Abbvie INC. | $54.82 | 2024 | |
| Mimedx Group, INC. | $54.29 | 2024-2025 | |
| Revance Therapeutics, INC. | $45.43 | 2024 | Daxxify |
| Angiodynamics, INC. | $37.50 | 2019-2024 | Venacure 1470 Pro |
| Siemens Medical Solutions USA, INC. | $28.22 | 2022 | |
| Hartmann USA, INC. | $24.73 | 2025 | Zetuvit Plus 10x10 P10 |
| Bsn Medical INC | $23.24 | 2022 | |
| Lilly USA, LLC | $17.15 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manu Aggarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.